FDA 483 - AdDent, Inc. - July 24, 2026

AdDent, Inc. in Danbury, CT, was cited for significant deficiencies in its quality system during an FDA inspection. The firm failed to maintain complete batch records, adequately assess design changes for regulatory impact, and properly manage supplier evaluations, alongside issues with purchased product verification and document control.